Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pretty Clear. Thanks cowboydancer!
I agree. Well, 2013 Q3 is already started on April 1st. So two of the milestones "Response to FDA questions: Q3 2013" and "In license Min technology: Q2 2013 "should be taken care anytime/anyday. That news itself should put this stock back over 1 or 2 cents.
One thing's for sure. At current PPS about .0040 BMSN is way way oversold. I was still surprised to see why 25% drop yesterday? Looks like there are lot of players involved with instant gratification expectations. I still have to find a penny stock that has potential like BMSN. I loved the latest PR, it was way different and detailed as compared to previous one. I hope they clear all FDA hurdles in few days and stock shoots up high.
There are so many garbage stocks out there that are trading at ridiculously trading at way higher levels. If BMSN's true potential is realised and MM's stop these mind games then I see no reason why this stock should not be trading over 10 or 20 cents now itself.
Time will tell!
Sure, you are welcome! I saw that too. We are still at the beginning of Q3 so may be we can get a PR on that too in near future. Good luck!
No.
October 1st 2012 is beginning of 1st quarter for year 2013.
October 1st 2013 is beginning of 1st quarter for year 2014.
For example for year 2012-2013
1st quarter --> oct,nov,dec of 2012 is 1st quarter of 2013
2nd quarter --> jan,feb,mar of 2013 is 2nd quarter of 2013
3rd quarter --> apr,may, june of 2013 is 3rd quarter of 2013
4th quarter --> july,aug,sep of 2013 is 4th quarter of 2013
So I believe April 1st, 2013 is beginning of 3rd quarter in 2013.
1st quarter --> oct,nov,dec
2nd quarter --> jan,feb,mar
3rd quarter --> apr,may, june
4th quarter --> july,aug,sep
Sterv, Haven't seen any posts from you on BMSN board for a long time. Would love to know your take on all the PR news.
Dr. Sophia Khaldoyanidi, Associate Member at Torrey Pines Institute for Molecular Studies (TPIMS), and her team of international collaborators recently discovered that the long-chain sugar molecule hyaluronan is important for the production of new blood cells in bone marrow. Millions of patients around the world suffer from acute and chronic illnesses caused by blood cell deficiencies resulting from damage to the bone marrow by chemotherapy, radiation, or disease. The new study, published in the July 20th, 2012 issue of the Journal of Biological Chemistry, could pave the way for new therapies that facilitate production of blood cells and improve the way that bone marrow stem cells are used to treat disease.
http://www.tpims.org/meet-our-scientists/california-scientists/sophia-khaldoyanidi
Jersey, You stop posting here just because someone calls you basher does not really makes sense.You can always put people on IGNORE who irritates you. I am sure there are still many longs left here with good intelligent posts. I think yesterday's PR was detailed one BMSN put so far. If everything works out the way outlined in that PR then I won't be surprised this stock trading over a buck soon. JMHO....
Moderator Please make this post# 58854 sticky.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=86249710
----------------------------------------------------------------------------------------------------------------------------------------
I've been doing some DD over the past day on why we are seeing the dilution over the last week. Make no mistake, we are seeing dilution here, but it is for a very good reason.
I poured over every SEC filing from the past year, and it should be mentioned that dilution has been steadily occurring over the past 12 months. In fact, the the A/S has increased twice from 500 milllion on 5/15/2012 to 1 billion on 5/16/2012. Check the filing here.
The next increase from 1 billion to 2 billion occurred on 10/23/2012. You can check the filing here.
While this sounds bad and it does actually reduce the value of the stock in which we hold, it is a necessary evil in order to fund the company through Phase 1 clinical trials.
The deal with Southridge was not necessary to just fund daily operations as the bashers want you to believe. Koos entered a deal with Southridge to put together the IND application and fund Phase 1 Clinical Trials. If he just wanted to fund daily operations, he could have done so by just diluting more shares of stock. The Southridge agreement up until recently has been in place to fund operations for the great scientific team that has been put together over last Summer. Read about it here, here, here, and here.
I think people on this board are confused with the equity agreement with Southridge. Yes, it is for up to $20 million; however, it is a share purchase agreement and Southridge will most likely never loan out the full $20 million. In fact, they are no where close to that amount at the moment. Here is the thing, Southridge can not own more than 9.99% of the O/S during this agreement during the 24 months starting 4/26/2012. THAT is why Koos has been increasing the A/S over the past year. In order for Southridge to be able to purchase more shares, Koos HAS to dilute the O/S. As of 11/30/2012, Southridge had purchased 46.2 million shares per a 13G here. This at the time represented 9.99% of the O/S. That is why you see dilution occurring throughout the month of December 2012. They needed to buffer the owned percentage amount by Southridge. Beneficially, the pps begins to rise at this point, and the dilution provides needed funds to get the IND application ready.
On a side note, an interesting thing happens here in the filings. The SGI Group LLC is compensated 30,303,030 shares. This is a Healthcare Technology Consultation firm. You can check out their website www.sgigroupllc.com. What is VERY interesting about this 13G filing is that is signed by the one and only Wayne Coleson from Vera Group LLC. The filing is here. Now Wayne has an association with SGI Group as a consultant himself, but from what I can tell from their website, he no longer is affiliated at the moment (they have a different venture capital guru). I'm not entirely sure what to think about this, but my gut is telling me that he oversaw what was happening, and decided he wanted a piece of the action himself. I could be way off base here, but why else would someone purchase 100 million shares on the open market of an at the time OTC:Pink company?
Ok, so this brings up back to our current situation. Why is dilution happening again? The O/S has increased from 1.2 billion to around 1.36 billion in the last two weeks as far as we can tell. This makes sense, because Koos needs Southridge to purchase more shares to fund Phase 1 Clinical Trials. Southridge's agreement states that the maximum amount of shares they can purchase at any given time is in the amount of $250K. Contrary to what most people on here think, these are not purchased on the open market. They are purchased directly from BMSN in the form of restricted shares. It is against everyone's best interest for these shares to be purchased at the lowest price possible, except for Southridge. Southridge wants the price as low as possible, but they cannot do anything about it because they are not allowed to short the stock (very smart on Koos' part when entering the agreement). However, due to the necessary dilution on Koos' part to free up wiggle room for Southridge to purchase more shares, panic sellers, and flippers, it has lowered the pps.
There is a lot of math involved here, but let's just say Southridge is going to purchase another $250K worth of shares at .005 pps. That amounts to another 50 million shares that Southridge is going to own very soon (if not already). They already own 46 million shares that we know. Therefore, Koos is probably going to max the amount they can own again to being 9.99% of the current O/S. That means Southridge is probably going to own about 96-135 million shares in the next few days. This number depends on how much Koos had them buy over January to February. I would be suprised, but not shocked if we did not get a 13G filing stating so. Now, by diluting the stock, it has also raised funds for BMSN. If they diluted it to the tune of 100 million (not the 600 million the bashers here want you to believe), that would probably amount to $550K at an average price of .0055. When you add the $250K from Southridge, that is about $800K of fresh funds.
Fresh funds for what? Well, according to Pharmalot here, that could be used to fund Phase 1 Clinical Trials. According to their estimates in 2011, it cost about $22K per patient to fund a Phase 1 Clinical Trial. Let's just say in 2013 that the amount is now $40K per patient. With a trial of 10 patients (as outlined in the BMSN IND), that would amount to $400K in cost for a Phase 1 Trial. Phase 2 and Phase 3 are on a much larger scale, and cost is 10-100 times what a Phase 1 costs. Therefore, that is when someone like PFE would step in if they liked what they saw from the Phase 1. If Phase 1 happens, and it is bad, BMSN will fall off the face of the Earth. However, we are not there, yet. The important thing is that BMSN now has the funds to initiate Phase 1 without big pharma.
Another important point is that there has not been a proxy vote for the increase in A/S over the last year. It is outlined by the SEC filing here. Koos has a majority of the voting power, and therefore, whatever he says goes.
At the moment, I think the dilution is slowing, and will soon come to an end. Anyone worried about the Southridge deal should not be, and I hope this post clarifies that. At most, I think Southridge has purchased around $1-$1.5 million worth of shares over the last year. As outlined in the agreement here there is virtually no way they can max out the $20 million agreement with a 9.99% ownership limit in place unless Koos decides to dilute the A/S to 1.6 trillion. Mark this post, THAT WILL NOT HAPPEN in the next 12 months. Per rule 144 of the SEC, Southridge can not sell thier shares for at least a year after their purchase since BMSN wasn't a fully reporting company at the time. So they will not be "dumping" their shares until at least this Summer when the pps should be much higher.
Understand that no one has been hurt more by this dilution that Koos and their employees. Koos has personally seen his share value drop from a 3% stake in the company to 0.88% stake over a 9 month period. That sucks big time for him, but he wouldn't be doing it if he didn't believe this company was headed for big things.
Also of note, anyone on here claiming that the company and affiliates are diluting and selling their shares because they know the IND is declined is most likely wrong. That would be insider trading, and becoming a fully reporting entity to the SEC is the last thing you want to do if you are doing such illegal activity. It would mean professional suicide for everyone involved, not to mention jail, and hefty fines. If they are doing that, it would be the dumbest thing they could possibly do at the moment. BMSN has been gaining a ton of exposure lately in the investment community and pharma community. This isn't a low level P&D right now. Southridge would absolutely report them, and everyone involved would see serious consequences.
If you gain anything from this post, understand that the dilution we are undergoing is a necessary evil for us to see a higher pps in the near future. Sit back and relax until future notice. If I am wrong in any part of this post, please provide solid evidence, and I will gladly admit I am wrong. Some of this post is speculative in regards to the amount of money being raised, but I feel it is pretty close to reality.
IMO
------------------------------------------------------------------------------------------------------------------------------------
Personally I don't like the way Dr. Koos is running the company and the attitude he shows towards shareholders. He lacks transparency.
But your post has bought some unknown prospects of the company to the surface and I thank you for that. I sincerely hope BMSN trades over a buck in future as per another investor's DD:
BMSN*Valuation, FDA, & Orphan Drug Thoughts…
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85795340
72chevnj,
i am not able to answer you privately. I understand PR costs money. But answer me this: Does answering investors queries costs money as well??
Stock has risen from .0002 to .0160 solely on hope for IND Approval.
Now that is NOT EXACTLY the case here and hence the sell-off was not a surprise. Long way to go before PPS stabilizes.
Well Done, Dr. Koos!
You know exactly how to s-c-r-*-w your loyal shareholders. This is a ideal scenario for you. Shareholders don't complain. They have 100% faith in you. They praise you all the time. Good for you
Now how long you are gonna be silent?? I guess another 30 days? Wow!! May be a PR after PPS reaches below .0010???
Who are "we" ?
Please find a way to lift this stock to one cent before IND approval. I will be very happy!
Before all these big dreams we need something called "IND Approval" which is in doubt now.
Please! You are so wrong!!
Gawd! Not again!
30 million BUY = 30 million SELL.
What's so different here?
There is a reason why AMBS went to 20 cents even without IND news. It is because of mutual trust between the CEO of AMBS Mr. Gerald and common shareholders. Mr. Gerald even has started a blog where he keeps shareholders updated on latest progress company makes.
What our great CEO Dr. Koos has done so far with regards to transparency. He instead sent a confused PR. He opens his mouth when not needed and keeps quiet when needed.
He don't seems to value shareholders sentiments a bit.
People who wants BMSN to act like AMBS needs to understand this fact.
Read the FDA response again. I am trying to get FDA IND receipt from BMSN CEO so that we will know the time-frame for next PR.
Jeez, I am tired of explaining this simple fact. Now please don't tell me that's is "insider" info. Jeez!!
Still think I wasted my time emailing Dr. Koos? It was a "I opener event". Well if everybody emails then he should atleast reply to one person. Don't you think so? May be another 25-50% downside will open your eyes??
I am so astonished to see so called "pumpers" here don't see any problem with Dr. Koos. I think they pretend to be "longs" but actually they are not invested. What a shame!
Sure. Here it is: DRUGINFO@fda.hhs.gov
Again asking for FDA receipt Date for IND is not asking inside informaton. I have sent over 20 emails over last two months and NOT A SINGLE REPLY FROM CEO??? How can you justify that action???
Read this also: This is from FDA.
Dear Peter,
Thank you for writing the Division of Drug Information, in the FDA's Center for Drug Evaluation and Research (CDER).
Please note that the FDA is only able to provide information on approved drug product applications. Any information on an application that has yet to receive an approval or was denied approval belongs to the manufacturer/sponsor developing the drug (21 CFR 314.430). Therefore, this proprietary information, including IND application information, is not releasable from the FDA. We encourage you to contact the sponsor directly to inquire about products under development.
Information on specific approved NDAs or ANDAs may be found on Drugs@FDA at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm.
Best regards,
B.C.
Drug Information Specialist | Division of Drug Information
Center for Drug Evaluation and Research | Food and Drug Administration
For up-to-date drug information, follow the FDA's Division of Drug Information on Twitter at FDA_Drug_Info
This communication is consistent with 21CFR10.85(k) and constitutes an informal communication that represents our best judgment at this time but does not constitute an advisory opinion, does not necessarily represent the formal position of the FDA, and does not bind or otherwise obligate or commit the agency to the views expressed.
From: Peter Gates [mailto:petergates9@yahoo.com]
Sent: Wednesday, March 20, 2013 11:16 AM
To: CDER DRUG INFO
Subject: Request: Status of IND number 15376
Hello,
Can you please provide the status of IND number 15376 for its proposed Phase I/II clinical trial evaluating use of its stem cell product, HemaXellerate, for treatment of aplastic anemia? Is it on Hold? What are the area(s) of clarification needed?
Thanks in advance.
Peter
Scary!
Asking FDA receipt Date of IND is not insider question. Jeez!
Apple and Microsoft has IR division to answer any queries investors want to ask. Unfortunately Dr. Koos is CEO as well as Janitor of BMSN
I think every shareholder here has the right to know this basic info from the company they are invested in. I have sent this message week ago and still waiting for the response. Answer to these questions will give investors rough idea how much more days/weeks they have to wait till next PR. But deep down I know Dr. Koos will never ever reply to email or for that fact any other investor as well.
This very fact raises the concerns like company is legit or not.
Now one line pumpers can call me "basher" for bringing this fact to the surface.
Try yourself and see what happens. Email (dkoos@bmsn.us) I sent Week ago and still waiting for reply is as follows:
----------------------------------------------------------------
Hello Dr. Koos,
I am a shareholder of your company. Could you please give following basic info. regarding recent IND 15376?
Date of receipt of the IND by FDA
Date on which IND number 15376 is assigned
Thanks in advance!
Peter
------------------------------------------------------------------
It better close in GREEN today. If RED then following week will be total bloodbath.
Main problem here is uncertainity.
This stock is hanging on only one thing FDA approval for trails. Last 2 weeks people knew waiting period will be around 30 days from Feb 5th. So on approval anticipation stock surged from sub-penny to .016.
Now no one knows when FDA approval going to be and Dr. Koos went for hibernation. MMs are willing to take the risk and nicely manipulating the situation.
Where's SKelly22??
We exchanged a fight other day how late PR IND news will affect stock PPS when BMSN was trading around .012. He/She was arguing with me other day saying I am gasping for Straws because stock is headed to 2 cents.
I didn't see posts from him/her for last 2-3 days? what's up???
There are strong reasons why stock is going south.
How long we are going to kid ourselves?
Day 1 --> No news closed 15% down
Day 2 --> No news closed 10% down
Day 3 --> No news closed 35% down
Day 4 --> No news closed ? % down
Day 5 --> No news closed ? % down
Day 6 --> No news closed ? % down
Day 7 --> No news closed ? % down
......
.......
......
.............
.............
.............
.............
.............
.......
Dr. Koos you need to throw a bone here. This time make sure it is a real bone not plastic bone like last time
If something that needs for this stock to move upwards over 5 cents is FDA Approval of IND Period. Till then Dr. Koos will make sure shareholders are toasted and roasted again and again.
Stocks even listed on Amex/Nasdaq are manipulated to grave level.
All this OTC junk listing will have no role to play in terms of PPS.
It is really sad that the stock has to come to a level where it has to depend on trivial things like this to stabilize.
Posters like you make me Puke.
Try spreading one line pumping
"we are on OTCBB going to moon" etc. Duh!
Here I make your DD 90% easier:
Check the top most intelligent poster of this board named STREVC
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85227700
Actually the board still has many intelligent posters. Stock has potential. It is the CEO who is sceeeewing the longs with his abnormal mental foolhardiness.
If you can get hold of CEO over email or phone and share some info. that would be beneficial. I gave up hope on that matter.
It is not the fluffPR. What is missing is transparency between your invested money and stock price. Get it?????
If that's the case don't email and just wait. Watch the stock go lowest levels everyday .0050, .0040, .0030, .0010..... with no apparent news.
How Pathetic we can't get this basic info from company itself. We have to assume everything. Thanks to Dr. Koos for srcewing us royally!!
Can you explain?
-------------------------------------------------------------
5) new funding strategy to pay for phase 1&2
-------------------------------------------------------------
why you said
"investors will know in a few weeks" ?
Why not within days?? This is the exact reason i was urging everyone flood the Koos's email box with questions.
He can not treat shareholders like dirt bags. We have right to know the every detail about the recent IND.
If this stock trades another one week with no PR, it will go below .0040 or even lower. MMs are very clever.
Trust me he needs to communicate that better way! PPS would have over 5 cents if that's true. He created a havoc with that unnecessary PR. Now he is not available by email or phone to clarify also. Duh!